Loading…
Cian Healthcare (BSE 542678)₹37.68+4.00%Pharmaceuticals
Cian Healthcare is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −16.1% against a peer median of 7.9%, and latest-quarter sales growth of 41.6% against a peer median of 36.1%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tyche Industries | 109 | 15.9 | 6.8 | 5.0 | 0.00 | 2.8 | 54 | 7 | 31.0 | 22.1 | vs BSE 542678 |
| Pharmaids Pharmaceuticals | 106 | — | −18.4 | −26.5 | 0.49 | 0.0 | 28 | −12 | −38.2 | — | vs BSE 542678 |
| Veerhealth Care | 103 | 177.3 | 7.2 | 3.0 | 0.20 | 0.0 | 33 | 1 | 198.0 | — | vs BSE 542678 |
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs BSE 542678 |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | — |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs BSE 542678 |
| Mercury Laboratories | 88 | 21.2 | 12.1 | 9.1 | 0.14 | 0.5 | 76 | 5 | −12.0 | −69.8 | vs BSE 542678 |
| Amwill Health Care | 87 | 7.6 | 21.1 | 15.4 | 0.00 | 1.2 | 43 | 11 | 41.1 | 100.0 | vs BSE 542678 |
| Jfl Life Sciences | 85 | 13.0 | 18.0 | 15.0 | 0.47 | 0.0 | 131 | 6 | −4.2 | 48.6 | vs BSE 542678 |
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs BSE 542678 |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs BSE 542678 |
| Peer median | 91 | 21.2 | 7.9 | 6.0 | 0.20 | 0.0 | 54 | 4 | 36.1 | 48.6 |
Listed companies closest to Cian Healthcare in Pharmaceuticals include Tyche Industries, Pharmaids Pharmaceuticals, Veerhealth Care, Concord Drugs, Vaishali Pharma, Mercury Laboratories, Amwill Health Care, Jfl Life Sciences.
Tyche Industries, with a market cap of ₹109 Cr.
Cian Healthcare's return on capital employed is −16.1%, below the peer median of 7.9%.